NEW YORK — Hurt by a weak U.S. retail scene and the impact of SARS, Elizabeth Arden Inc.’s first-quarter sales dipped while red ink pooled on the bottom line.

Losses attributable to common shareholders widened to $16.7 million, or 93 cents a share, for the three months ended April 26. This compared with the year-ago loss of $10.8 million, or 61 cents.

To Read the Full Article

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus